Found: 24
Select item for more details and to access through your institution.
Individualized busulfan dosing improves outcomes compared to fixed‐dose administration in pre‐transplant minimal residual disease‐positive acute myeloid leukemia patients with intermediate‐risk undergoing allogeneic stem cell transplantation in CR
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 188, doi. 10.1111/ejh.13893
- By:
- Publication type:
- Article
Role of pre‐transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 5, p. 606, doi. 10.1111/ejh.13557
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 6, p. 552, doi. 10.1111/ejh.13318
- By:
- Publication type:
- Article
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 3, p. 305, doi. 10.1111/ejh.13099
- By:
- Publication type:
- Article
Comparison of single copy gene-based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19-directed CAR T cells in treated patients.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 5, p. N.PAG, doi. 10.3892/ijo.2022.5338
- By:
- Publication type:
- Article
Low frequency of calreticulin mutations in MDS patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 9, p. 1933, doi. 10.1038/leu.2014.165
- By:
- Publication type:
- Article
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 7, p. 1552, doi. 10.1038/leu.2014.66
- By:
- Publication type:
- Article
Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.
- Published in:
- Clinical & Experimental Medicine, 2010, v. 10, n. 3, p. 205, doi. 10.1007/s10238-009-0058-9
- By:
- Publication type:
- Article
Use of ropeginterferon in inducing graft versus myelofibrosis effect in post‐transplant myelofibrosis relapse.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 3, p. 403, doi. 10.1038/bmt.2012.142
- By:
- Publication type:
- Article
Circulating CD34<sup>+</sup> cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 9, p. 1404, doi. 10.1038/bmt.2009.367
- By:
- Publication type:
- Article
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44<sup>+</sup>) and T (HLA-DR<sup>+</sup>) cells.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 2, p. 349, doi. 10.1038/bmt.2009.155
- By:
- Publication type:
- Article
Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 3, p. 288, doi. 10.1111/ejh.12724
- By:
- Publication type:
- Article
Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 3, p. 189, doi. 10.1111/ejh.12223
- By:
- Publication type:
- Article
Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. 484, doi. 10.1111/bjh.15952
- By:
- Publication type:
- Article
Immunomagnetic tumor cell selection--implications for the detection of disseminated cancer cells.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Indication of Horizontal DNA Gene Transfer by Extracellular Vesicles.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163665
- By:
- Publication type:
- Article
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Clinical Chemistry, 2023, v. 69, n. 3, p. 295, doi. 10.1093/clinchem/hvac214
- By:
- Publication type:
- Article
Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/652130
- By:
- Publication type:
- Article
Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCR.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1970, doi. 10.3390/cancers12071970
- By:
- Publication type:
- Article
5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity.
- Published in:
- Mediators of Inflammation, 2014, v. 2014, p. 1, doi. 10.1155/2014/418292
- By:
- Publication type:
- Article
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 6, p. 1145, doi. 10.3390/pharmaceutics14061145
- By:
- Publication type:
- Article